QV Bioelectronics CEO Dr Chris Bullock Gives Evidence as an Industry Expert to the All-Party Parliamentary Group on Brain Tumours (APPGBT)

June 1

The All-Party Parliamentary Group on Brain Tumours (APPGBT) held a fifth oral evidence session today as part of its ongoing inquiry, Pathway to a Cure – breaking down the barriers.

The witnesses for the session held on the 24th May represented industry and included QV Bioelectronics alongside Northwest Biotherapeutics, Extruded Pharmaceuticals and Oncologica.

The roles of Government, the NHS and Universities were scrutinised in a lively session that gave panel members much to ponder and led to a series of recommendations that are likely to form part of the inquiry report that will be delivered early in 2023.